Is Microgestin (ethinyl estradiol / norethindrone acetate) covered by Medicare Part D?
4,817 of 5,052 Medicare Part D plan offerings (95.3%) list Microgestin on their 2026 formulary, most often on tier 2; 0% of the formularies that cover it require prior authorization. Part D spending on it was $83 thousand in 2024 for 750 people: what plans and patients paid at the pharmacy, before manufacturer rebates (CMS Part D Spending by Drug).
- Plans that cover it
- 95.3%
- 4,817 of 5,052 offerings; the median drug: 76%
- Usual tier
- Tier 2
- from tier 1 to tier 4
- Prior authorization
- 0%
- of formularies that cover it; the median drug: 1%
- Quantity limits
- 0%
- of formularies that cover it; the median drug: 30%
Source: CMS Part D formulary file, 2026 second quarter: the formularies in use in 2026. A plan's 2027 formulary can differ; check your own plan's coverage in Medicare Plan Finder.
What does it cost under Part D in 2027?
- Your yearly cap in 2027
- Out-of-pocket spending on covered Part D drugs stops at $2,400 in 2027 ($2,100 in 2026); after that, you pay nothing for covered drugs for the rest of the year.
- The deductible
- A plan's drug deductible is at most $700 in 2027 ($615 in 2026); many plans charge less or none.
Source: CMS, Announcement of calendar year 2027 Part D parameters; Medicare.gov, “How much does Medicare drug coverage cost?” (read Oct. 7, 2026).
How much does Medicare spend on it?
Part D spending by year
750 people filled it under Part D in 2024, in 3,190 claims. The amounts are what plans and patients paid at the pharmacy, before manufacturer rebates.
Source: CMS Medicare Part D Spending by Drug, 2020 to 2024 (published June 2026). Row used: Microgestin (Norethindrone Ac/Eth Estradiol).
Which forms and strengths are counted?
- pack of 21 × ethinyl estradiol 0.02 mg / norethindrone acetate 1 mg oral tablet
- pack of 21 × ethinyl estradiol 0.03 mg / norethindrone acetate 1.5 mg oral tablet
Which other versions are listed?
The same ingredients under other names, each with its own coverage and spending.
- Ethinyl estradiol / norethindrone acetate97.2% of plan offerings
- Junel Fe (ethinyl estradiol / norethindrone acetate)97.2% of plan offerings
- Microgestin Fe (ethinyl estradiol / norethindrone acetate)95.9% of plan offerings
- Larin Fe (ethinyl estradiol / norethindrone acetate)95.3% of plan offerings
- Larin (ethinyl estradiol / norethindrone acetate)95% of plan offerings
- Tarina Fe (ethinyl estradiol / norethindrone acetate)94.8% of plan offerings
- Junel (ethinyl estradiol / norethindrone acetate)92.9% of plan offerings
- Blisovi 21 Fe (ethinyl estradiol / norethindrone acetate)92.6% of plan offerings
- Hailey Fe (ethinyl estradiol / norethindrone acetate)88.2% of plan offerings
- Tri-Legest (ethinyl estradiol / norethindrone acetate)86.3% of plan offerings
- Luizza (ethinyl estradiol / norethindrone acetate)86% of plan offerings
- Feirza (ethinyl estradiol / norethindrone acetate)85.3% of plan offerings
- Tilia Fe (ethinyl estradiol / norethindrone acetate)85.2% of plan offerings
- Xarah Fe (ethinyl estradiol / norethindrone acetate)83.5% of plan offerings
- Tarina 24 FE (ethinyl estradiol / norethindrone acetate)78.5% of plan offerings
- Hailey 24 Fe (ethinyl estradiol / norethindrone acetate)77.3% of plan offerings
- Blisovi 24 Fe (ethinyl estradiol / norethindrone acetate)76.1% of plan offerings
- Fyavolv (ethinyl estradiol / norethindrone acetate)66.2% of plan offerings
- Jinteli (ethinyl estradiol / norethindrone acetate)66.2% of plan offerings
- Loestrin (ethinyl estradiol / norethindrone acetate)55.3% of plan offerings
- Loestrin Fe (ethinyl estradiol / norethindrone acetate)55.3% of plan offerings
- Finzala 24 Fe Chewable (ethinyl estradiol / norethindrone acetate)44% of plan offerings
- Mibelas 24 Fe Chewable (ethinyl estradiol / norethindrone acetate)39.1% of plan offerings
- Femlyv 24 ODT (ethinyl estradiol / norethindrone acetate)17.3% of plan offerings
- Gemmily (ethinyl estradiol / norethindrone acetate)7.8% of plan offerings
- Lo Loestrin Fe (ethinyl estradiol / norethindrone acetate)0.9% of plan offerings
What else should you check?
- Stand-alone drug plans for 2027Premiums and deductibles
- Drugs Medicare spends the most onThe 2024 spending list
- 2027 costs and limitsDeductibles and out-of-pocket limits
Data, not medical advice. Coverage is the share of plan formularies listing the drug; your plan's formulary, tier and pharmacy decide what you pay.